Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
Tipo de estudo
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Cell ; 175(5): 1405-1417.e14, 2018 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-30318144

RESUMO

Programmable control of spatial genome organization is a powerful approach for studying how nuclear structure affects gene regulation and cellular function. Here, we develop a versatile CRISPR-genome organization (CRISPR-GO) system that can efficiently control the spatial positioning of genomic loci relative to specific nuclear compartments, including the nuclear periphery, Cajal bodies, and promyelocytic leukemia (PML) bodies. CRISPR-GO is chemically inducible and reversible, enabling interrogation of real-time dynamics of chromatin interactions with nuclear compartments in living cells. Inducible repositioning of genomic loci to the nuclear periphery allows for dissection of mitosis-dependent and -independent relocalization events and also for interrogation of the relationship between gene position and gene expression. CRISPR-GO mediates rapid de novo formation of Cajal bodies at desired chromatin loci and causes significant repression of endogenous gene expression over long distances (30-600 kb). The CRISPR-GO system offers a programmable platform to investigate large-scale spatial genome organization and function.


Assuntos
Sistemas CRISPR-Cas/genética , Edição de Genes/métodos , Genoma , Ácido Abscísico/farmacologia , Linhagem Celular Tumoral , Cromatina/genética , Cromatina/metabolismo , Corpos Enovelados/genética , Regulação da Expressão Gênica , Loci Gênicos , Humanos , Hibridização in Situ Fluorescente , Pontos de Checagem da Fase S do Ciclo Celular/efeitos dos fármacos
2.
Science ; 365(6459): 1301-1305, 2019 09 20.
Artigo em Inglês | MEDLINE | ID: mdl-31488703

RESUMO

We report a robust, versatile approach called CRISPR live-cell fluorescent in situ hybridization (LiveFISH) using fluorescent oligonucleotides for genome tracking in a broad range of cell types, including primary cells. An intrinsic stability switch of CRISPR guide RNAs enables LiveFISH to accurately detect chromosomal disorders such as Patau syndrome in prenatal amniotic fluid cells and track multiple loci in human T lymphocytes. In addition, LiveFISH tracks the real-time movement of DNA double-strand breaks induced by CRISPR-Cas9-mediated editing and consequent chromosome translocations. Finally, by combining Cas9 and Cas13 systems, LiveFISH allows for simultaneous visualization of genomic DNA and RNA transcripts in living cells. The LiveFISH approach enables real-time live imaging of DNA and RNA during genome editing, transcription, and rearrangements in single cells.


Assuntos
Sistemas CRISPR-Cas , Edição de Genes , Hibridização in Situ Fluorescente/métodos , Linhagem Celular Tumoral , DNA/análise , Quebras de DNA de Cadeia Dupla , Vetores Genéticos , Células HEK293 , Humanos , Microscopia de Fluorescência , Imagem Molecular , RNA/análise , RNA Guia de Cinetoplastídeos/genética , Linfócitos T
3.
Neurol Res ; 25(1): 22-6, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12564121

RESUMO

Nosocomial infections affect a significant number of intensive care unit (ICU) patients including those in the neurosurgical ICU. Gram-positive organisms are responsible for many of these infections and often these pathogens are resistant to some of the older antimicrobial agents. Two new classes of antibiotics have been developed: streptogramins and oxazolidinones. Linezolid is an oxazolidinone, which has been shown to be effective against methicillin- and vancomycin-resistant Gram-positive pathogens. It may be administered orally or parenterally, and displays favorable pharmacokinetic properties, with rapid and complete absorption after oral administration. Linezolid is generally well tolerated with mild gastrointestinal related adverse effects. Linezolid provides a useful alternative in the treatment of Gram-positive infections, particularly those caused by resistant organisms. It has tremendous clinical utility, especially in the ICU where infections and multi-drug resistant rates are high and treatment options become limited.


Assuntos
Acetamidas/farmacologia , Acetamidas/uso terapêutico , Anti-Infecciosos/farmacologia , Anti-Infecciosos/uso terapêutico , Infecção Hospitalar/tratamento farmacológico , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Oxazolidinonas/farmacologia , Oxazolidinonas/uso terapêutico , Acetamidas/economia , Animais , Anti-Infecciosos/economia , Infecção Hospitalar/etiologia , Infecção Hospitalar/microbiologia , Infecções por Bactérias Gram-Positivas/microbiologia , Humanos , Unidades de Terapia Intensiva , Linezolida , Procedimentos Neurocirúrgicos/efeitos adversos , Oxazolidinonas/economia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA